Escitalopram and Navelbine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Navelbine (vinorelbine tartrate). Common drug interactions include neutropenia among females.

The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Navelbine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Navelbine?

Navelbine has active ingredients of vinorelbine tartrate. It is often used in breast cancer. eHealthMe is studying from 8,750 Navelbine users. Check the latest studies of Navelbine.



On Jul, 21, 2026

12 people who take Escitalopram and Navelbine together, and have interactions are studied.

Escitalopram and Navelbine drug interactions.

What are the common drug interactions of Escitalopram and Navelbine, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Anaemia (lack of blood)
  3. Bone disorder
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chest pain
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Confusional state
  8. Dental caries
  9. Diarrhoea
  10. Dizziness

male:

n/a

What are the common drug interactions of Escitalopram and Navelbine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Anaemia (lack of blood)
  3. Hepatotoxicity (chemical-driven liver damage)
  4. Pleural effusion (water on the lungs)

50-59:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Inappropriate antidiuretic hormone secretion

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Asthenia (weakness)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pain
  7. Pyrexia (fever)
  8. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

What are the existing conditions these people have? *

  1. Pain: 2 people, 16.67%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 16.67%
  4. Stress And Anxiety: 1 person, 8.33%
  5. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  6. Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 1 person, 8.33%
  7. Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 1 person, 8.33%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%
  9. Cancer Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and Navelbine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Escitalopram and Navelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Navelbine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Escitalopram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Navelbine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and vinorelbine tartrate (the active ingredients of Escitalopram and Navelbine, respectively), and Escitalopram and Navelbine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: